Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayen

Showing results (461-470 of 482) with videos related to

Pageof 49
Sort By:
The Cochrane Database of Systematic Reviews|February 10, 2021
Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care settingMichelle Kokkinou, Lucy C Beishon, Nadja Smailagic, et al.
Frontiers in Psychiatry|November 30, 2020
Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study ProtocolAmy C Bilderbeck, Andreea Raslescu, Dennis Hernaus, et al.
Neuroscience and Biobehavioral Reviews|November 7, 2018
Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selectionGary Gilmour, Stefano Porcelli, Valérie Bertaina-Anglade, et al.
Clinical Laboratory|July 13, 2012
Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptideBo Jørgensen, Thomas Bertsch, Hans-Joachim Bröker, et al.
The European Respiratory Journal|February 25, 2017
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Christopher Grainge, et al.
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2012
Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5Roine I Olsson, Ingemar Jacobson, Jonas Boström, et al.
Molecular & Cellular Proteomics : MCP|September 5, 2007
Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profilingSebastian Wiese, Thomas Gronemeyer, Rob Ofman, et al.
Journal of the American Chemical Society|February 24, 2021
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Thazha P Prakash, Richard Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementiaAnna H Noel-Storr, Leon Flicker, Craig W Ritchie, et al.
Pageof 49

Showing results (461-470 of 482) with videos related to

Sort By:
Pageof 49
The Cochrane Database of Systematic Reviews|February 10, 2021
Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care settingMichelle Kokkinou, Lucy C Beishon, Nadja Smailagic, et al.
Frontiers in Psychiatry|November 30, 2020
Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study ProtocolAmy C Bilderbeck, Andreea Raslescu, Dennis Hernaus, et al.
Neuroscience and Biobehavioral Reviews|November 7, 2018
Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selectionGary Gilmour, Stefano Porcelli, Valérie Bertaina-Anglade, et al.
Clinical Laboratory|July 13, 2012
Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptideBo Jørgensen, Thomas Bertsch, Hans-Joachim Bröker, et al.
The European Respiratory Journal|February 25, 2017
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Christopher Grainge, et al.
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2012
Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5Roine I Olsson, Ingemar Jacobson, Jonas Boström, et al.
Molecular & Cellular Proteomics : MCP|September 5, 2007
Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profilingSebastian Wiese, Thomas Gronemeyer, Rob Ofman, et al.
Journal of the American Chemical Society|February 24, 2021
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Thazha P Prakash, Richard Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementiaAnna H Noel-Storr, Leon Flicker, Craig W Ritchie, et al.
Pageof 49